首页> 美国卫生研究院文献>Clinical and Experimental Hepatology >Spontaneous bacterial peritonitis – therapeutic challenges in the era of increasing drug resistance of bacteria
【2h】

Spontaneous bacterial peritonitis – therapeutic challenges in the era of increasing drug resistance of bacteria

机译:自发性细菌性腹膜炎–细菌耐药性增强时代的治疗挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Spontaneous bacterial peritonitis (SBP) is one of the most common bacterial infections in patients with liver cirrhosis and it significantly contributes to the deterioration of the prognosis and increased risk of mortality. Previous data suggested that the most common pathogens causing SBP are G-negative aerobic bacteria and treatment recommended by the international guidelines (EASL, AASLD) is highly effective.In recent years, due to the widespread use of antibiotic prophylaxis and the increased frequency of hospitalization along with the use of invasive procedures in patients with cirrhosis, the involvement of Gram-positive cocci and multi-drug resistant bacteria in the etiology of SBP is increasing. This is related to the lowering of the effectiveness of the first-line therapy used so far and worsening of the prognosis, increasing in-hospital mortality. In this work we summarize current data on the characteristics of pathogens responsible for SBP in the context of currently recommended treatment regimens.
机译:自发性细菌性腹膜炎(SBP)是肝硬化患者中最常见的细菌感染之一,它显着地导致了预后的恶化和死亡风险的增加。以前的数据表明,引起SBP的最常见病原体是G阴性需氧菌,并且国际准则(EASL,AASLD)推荐的治疗非常有效。近年来,由于抗生素的广泛使用和住院次数的增加随着肝硬化患者采用侵入性治疗,革兰氏阳性球菌和耐多药细菌在SBP病因中的参与度正在增加。这与迄今为止使用的一线治疗的有效性降低和预后恶化,医院内死亡率增加有关。在这项工作中,我们在当前推荐的治疗方案的背景下总结了有关SBP病原体特征的最新数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号